Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0000899243-21-020247

Options or other derivatives

  • Director acquired 56,670 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Adams Jerome M. Director 2021-05-18 Grant or award · Stock Option (Right to Buy) +56,670 56,670 D
Loading xslF345X03/doc4.xml…